• Media type: E-Article
  • Title: 225.3: Randomized phase 2 trial of felzartamab in humoral transplant rejection
  • Contributor: Mayer, Katharina; Schrezenmeier, Eva; Diebold, Matthias; Halloran, Philip F; Schatzl, Martina; Kainz, Alexander; Eskandary, Farsad; Doberer, Konstantin; Patel, Uptdal D; Dudani, Jaideep S; Regele, Heinz; Kozakowski, Nicolas; Kläger, Johannes; Amann, Kerstin; Puchhammer-Stöckl, Elisabeth; Vietzen, Hannes; Beck, Julia; Schütz, Ekkehard; Akifova, Aylin; Osmanodja, Bilgin; Halleck, Fabian; Jilma, Bernd; Budde, Klemens; Böhmig, Georg A
  • Published: Ovid Technologies (Wolters Kluwer Health), 2024
  • Published in: Transplantation, 108 (2024) 9S
  • Language: English
  • DOI: 10.1097/01.tp.0001064412.57521.63
  • ISSN: 0041-1337; 1534-6080
  • Origination:
  • Footnote: